XML 82 R60.htm IDEA: XBRL DOCUMENT v3.25.0.1
Acquisitions and divestitures - Schedule of Supplemental Pro Forma Financial Information (Details) - Horizon Therapeutics - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Business Acquisition [Line Items]    
Total revenues $ 30,969 $ 29,964
Net income $ 5,383 $ 2,381